Discussion: The prevalence of the
E157Q polymorphic mutation was 2.7% in
INSTIs-naive patients from 17 French clinical centers, and 2.4% in ART-naive patients in Italy.
Discussion: These studies have demonstrated that the
E157Q mutation itself has minimal effects on RAL and DTG activity and viral infectivity.